Standout Papers

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects 2022 2026 2023 2024114
  1. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects (2022)
    Shengjie Tang, Chao Qin et al. Cells

Citation Impact

9 standout
Sub-graph 1 of 5

Citing Papers

Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications
2024 Standout
Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
2024 Standout
2 intermediate papers

Works of Shoujun Tang being referenced

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
2022
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
2021

Author Peers

Author PRM Surgery Molecular Biology Oncology Last Decade Papers Cites
Shoujun Tang 117 27 107 114 11 263
Palash Pandit 65 10 13 433
Allen Burke 584 530 9 29 5 830
Wei‐Hua Luo 23 349
Marco Bagliacca 1 9 7 71 355
Fengrong Wei 2 64 2 14 572

All Works

Loading papers...

Rankless by CCL
2026